Literature DB >> 24467605

The potential role of angiogenic factors in rheumatoid arthritis.

Gholamreza Azizi1, Roobina Boghozian, Abbas Mirshafiey.   

Abstract

Angiogenesis is an important phenomenon in the pathogenesis of some diseases, such as numerous types of tumors and autoimmunity, and also a number of soluble and cell-bound factors may stimulate neovascularization in inflammatory reaction processes. Here, by highlighting the significance of angiogenesis reaction in rheumatoid arthritis (RA), we will mainly focus on the role of various growth factors, cytokines, enzymes, cells, hypoxic conditions and transcription factors in the angiogenic process and we will then explain some therapeutic strategies based on blockage of angiogenesis and modification of the vascular pathology in RA.
© 2014 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  RA; VEGF; angiogenesis; cytokines; hypoxia

Mesh:

Substances:

Year:  2014        PMID: 24467605     DOI: 10.1111/1756-185X.12280

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  18 in total

1.  YWHAH Genetic Variants are Associated with Increased Hypoxia Inducible Factor-1α/Vascular Endothelial Growth Factor in Egyptian Rheumatoid Arthritis Patients.

Authors:  Shaimaa A Fattah; Maha A Abdel Fattah; Noha M Mesbah; Samy M Saleh; Dina M Abo-Elmatty; Eman T Mehanna
Journal:  Biochem Genet       Date:  2022-02-21       Impact factor: 1.890

Review 2.  Elucidating the role of hypoxia-inducible factor in rheumatoid arthritis.

Authors:  Essa M Sabi; Anuja Singh; Ziyad M Althafar; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harrasi; Hosam M Alqahtani; Simona Bungau
Journal:  Inflammopharmacology       Date:  2022-04-01       Impact factor: 4.473

3.  Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.

Authors:  Morouj Ismail; Ghada Khawaja
Journal:  Clin Rheumatol       Date:  2018-07-21       Impact factor: 2.980

Review 4.  Advances and challenges in hemophilic arthropathy.

Authors:  Tine Wyseure; Laurent O Mosnier; Annette von Drygalski
Journal:  Semin Hematol       Date:  2015-10-26       Impact factor: 3.851

5.  Hic-5 mediates the initiation of endothelial sprouting by regulating a key surface metalloproteinase.

Authors:  Jui M Dave; Colette A Abbey; Camille L Duran; Heewon Seo; Gregory A Johnson; Kayla J Bayless
Journal:  J Cell Sci       Date:  2016-01-14       Impact factor: 5.285

6.  Systemic pharmacological investigation of the Feng Shi Gu Tong capsule in the treatment of rheumatoid arthritis.

Authors:  Xin Wei; Wanjin Fu; Renpeng Zhou; Yong Chen; Chao Lu; Wei Hu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-01       Impact factor: 3.000

7.  The Annexin a2 Promotes Development in Arthritis through Neovascularization by Amplification Hedgehog Pathway.

Authors:  Jun Yi; Yan Zhu; Yin Jia; Hongdie Jiang; Xin Zheng; Dejing Liu; Shunxiang Gao; Mingjuan Sun; Bo Hu; Binghua Jiao; Lianghua Wang; Kaihui Wang
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

8.  Cardamonin Regulates miR-21 Expression and Suppresses Angiogenesis Induced by Vascular Endothelial Growth Factor.

Authors:  Fu-Sheng Jiang; Sha-Sha Tian; Jin-Jian Lu; Xing-Hong Ding; Chao-Dong Qian; Bin Ding; Zhi-Shan Ding; Bo Jin
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

9.  Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis.

Authors:  Agnieszka Paradowska-Gorycka; Andrzej Pawlik; Katarzyna Romanowska-Prochnicka; Ewa Haladyj; Damian Malinowski; Barbara Stypinska; Malgorzata Manczak; Marzena Olesinska
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

Review 10.  Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis.

Authors:  Susan Hua; Thilani H Dias
Journal:  Front Pharmacol       Date:  2016-06-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.